This inventor holds 2 USPTO granted patents. Top assignees: Iflo-Istituto Farmacologico Lombardo S.a.s. Di Giorgio E Ald. Laguzzi, Instituto Farmacologico Lombardo-Iflo, S.a.s.. Active years: 1995-1996.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 1995-1996
Title: Bojidar Stankov: Innovator in Pharmaceutical Compounds
Introduction
Bojidar Stankov is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of circadian rhythm disorders and sleep-related issues. With a total of 2 patents, his work showcases innovative approaches to enhancing therapeutic efficacy.
Latest Patents
Stankov's latest patents include compounds effective in the treatment of circadian rhythms. These novel compounds exhibit superior activity in addressing pathologies that interfere with the circadian rhythm. The compounds are characterized by specific formulas that include various chemical groups, demonstrating their potential in pharmaceutical applications. Additionally, he has developed pharmaceutical compositions active in the therapy of sleep disorders, which incorporate melatonin and its derivatives. These compositions are designed for effective dosage and can be administered in conjunction with benzodiazepinic derivatives.
Career Highlights
Throughout his career, Bojidar Stankov has worked with several prominent companies in the pharmaceutical sector. Notable among these are Iflo - Istituto Farmacologico Lombardo and Instituto Farmacologico Lombardo - Iflo, S.a.s. His work in these organizations has contributed to advancements in drug formulation and delivery methods.
Collaborations
Stankov has collaborated with esteemed colleagues such as Franco Fraschini and Gabriele Biella. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical field.
Conclusion
Bojidar Stankov's contributions to pharmaceutical innovations, particularly in the treatment of circadian rhythm disorders and sleep disorders, highlight his role as a significant inventor in the industry. His patents and collaborations reflect a commitment to advancing therapeutic solutions.